James E. Flynn - 30 Sep 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics, Inc. Common Stock (CGEM)

Filing Manager
James E. Flynn
Reporting Manager
Deerfield Mgmt, L.P.
Security
Cullinan Therapeutics, Inc. Common Stock
Symbol
CGEM
Shares outstanding
59,131,576 shares
Disclosed Ownership
2,927,013 shares
Ownership
5%
Form type
SCHEDULE 13G/A
Filing time
13 Nov 2025, 16:28:46 UTC
Date of event
30 Sep 2025
SEC
View on sec.gov

Reporting Managers (4)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
Deerfield Mgmt, L.P. 5% 2,927,013 0 2,927,013 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Management Company, L.P. 5% 2,927,013 0 2,927,013 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
Deerfield Partners, L.P. 5% 2,927,013 0 2,927,013 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact
James E. Flynn 5% 2,927,013 0 2,927,013 /s/ Jonathan Isler Jonathan Isler, Attorney-In-Fact